Inventor profile of:

Daniel W. PIERCE

City:

Belmont, California

Country:

United States

Published Applications:

17

Last publication date:

2024-11-07

Top Assignees for applications by Daniel W. PIERCE

The entities that hold a legal rights for patent applications filed by inventor PIERCE Daniel W.:

Recent patent applications by PIERCE Daniel W.

Daniel W. PIERCE from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07
US20240366593A1
Human necessities

ANTIPROLIFERATIVE COMPOUNDS AND BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 FOR COMBINED USE

#2 | 2024-06-27
US20240207255A1
Human necessities

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

#3 | 2023-10-26
US20230341375A1
Physics

METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE

#4 | 2023-08-03
US20230243806A1
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#5 | 2023-06-15
US20230181575A1
Human necessities

Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use

#6 | 2022-09-08
US20220280505A1
Human necessities

Antiproliferative compounds and methods of use thereof

#7 | 2022-05-03
US16887609
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#8 | 2021-06-17
US20210181184A1
Physics

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

#9 | 2021-05-06
US20210128545A1
Human necessities

Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

#10 | 2020-08-13
US20200253964A1
Human necessities

Antiproliferative compounds and methods of use thereof

#11 | 2020-07-07
US16277265
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#12 | 2020-01-07
US15062050
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel

#13 | 2019-12-19
US20190381035A1
Human necessities

Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use

#14 | 2019-11-28
US20190361005A1
Physics

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

#15 | 2019-09-19
US20190282567A1
Human necessities

Antiproliferative compounds and methods of use thereof

#16 | 2019-01-10
US20190008852A1
Human necessities

Antiproliferative compounds and methods of use thereof

#17 | 2018-03-08
US20180064679A1
Human necessities

METHOD FOR TREATING CANCER BASED ON LEVEL OF GLUCOCORTICOID RECEPTOR

InventorID:

2133174 ⎘